NCT06502964: An ongoing trial by Alto Neuroscience
This trial is ongoing. It must report results 10 months, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06502964 |
|---|---|
| Title | Double-Blind, Placebo-Controlled Study of ALTO-101 in Patients With Schizophrenia and Cognitive Impairment |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 11, 2024 |
| Completion date | Feb. 28, 2026 |
| Required reporting date | Feb. 28, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |